Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots.
about
Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategiesNanotheranostics - application and further development of nanomedicine strategies for advanced theranosticsLiposomes as nanomedical devicesPaclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatmentAddressing taxane resistance in metastatic castration-resistant prostate cancer: a focus on chaperone proteins.Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Polymer-coated echogenic lipid nanoparticles with dual release triggers.Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery.Theranostic tumor homing nanocarriers for the treatment of lung cancerNanoways to overcome docetaxel resistance in prostate cancer.Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy.Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.Polymeric nanocomposites loaded with fluoridated hydroxyapatite Ln(3+) (Ln = Eu or Tb)/iron oxide for magnetic targeted cellular imaging.Utilizing the folate receptor for active targeting of cancer nanotherapeuticsFormulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity.Hybrid-Actuating Macrophage-Based Microrobots for Active Cancer Therapy.How nanotechnology can enhance docetaxel therapy.Current development in nanoformulations of docetaxel.Surface-functionalized nanoparticles for biosensing and imaging-guided therapeutics.Nanomicellar carriers for targeted delivery of anticancer agents.Design of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical application.Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence.Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles.Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate.A FRET-based dual-targeting theranostic chimeric peptide for tumor therapy and real-time apoptosis imaging.Nanoparticles of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate cancer cells.Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging.Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel.Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer.Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.Quantifying engineered nanomaterial toxicity: comparison of common cytotoxicity and gene expression measurements.Biomineral Nano-Theranostic agent for Magnetic Resonance Image Guided, Augmented Radiofrequency Ablation of Liver Tumor.Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics.Carbon nanotubes functionalized with folic acid attached via biomimetic peptide linker.cRGD-conjugated magnetic-fluorescent liposomes for targeted dual-modality imaging of bone metastasis from prostate cancer.Cationic liposomes produced via ethanol injection method for dendritic cell therapy.
P2860
Q26796704-61789EC7-C38F-4251-84FA-D88A1C0E99D4Q26860760-DF29ABCB-8902-4A16-A871-650C4AB047AAQ28088315-4F2401F5-D5D4-4CD4-BB52-E869127078EDQ28660945-DF57B38A-8088-41BA-8808-A4177420564AQ30244818-B1D6DC53-99EA-46B9-806E-90860727AD8DQ30354652-0D33540C-1007-40A8-87D6-EC3E2764348CQ30441883-089717A5-E89D-4E9D-875F-140DCDEE1C55Q33734382-901A0A1D-8126-4FFC-8DDD-344A22C7FA81Q33769951-F3332C5D-3065-410F-B562-97BB92DB12FCQ33909084-20250F6D-A0AB-41C4-8FB3-DAC0D54F2461Q33962553-E2F82458-E31B-46B4-A91D-0F4B1B454323Q34322427-83A75653-62B3-4022-BACA-8E507EC267C7Q35099618-7FD21DA9-A086-4C06-9D59-F2445EC45B52Q35815671-E6CAD59A-7E96-415B-913C-16E23EC9C3BAQ36463444-499C9B80-F327-4963-AC85-6EC1C287F734Q36949647-6369DC0F-326D-41C8-A1DE-FD22EFC7ADCFQ37039986-A998265B-D860-4D64-9A43-0649324FB504Q37091683-110467FE-8843-4ED9-8E4B-882288E3E7EDQ38019047-D77952ED-543B-4C0D-AD98-82AD41602786Q38088165-671E9CDB-E03D-4714-A893-701D6CF25B3BQ38171564-3BE3BE49-6EDE-47C4-B774-F9A71002AC91Q38691500-9C936AB3-6890-4979-993E-56FC128C6912Q38787524-A5DF17BE-DF85-4F22-954B-F0002C4C0982Q38853328-8FDFDB72-DF7F-4546-BCB4-EBE06997DAADQ38871546-8C12DBE4-3814-4FED-88CD-C1087709B909Q38885334-6B0988FB-2622-4055-A9A4-8B2D689C6A86Q38917679-B1CB95B5-0363-4EF7-B36B-7D1F15993D5EQ39007998-33289C1A-E7E0-4BE2-AC7B-88808ACEF9ABQ39016257-14B1B5CB-39E2-43D0-9587-EC025729D385Q39181552-099A3810-D18E-47E3-9932-80DA985A5FE9Q39185708-23ABCC6A-FEA1-4579-ADC4-0BF4FE2C724BQ41181847-B58C02CC-9CEE-49AB-825F-9D857014C4B4Q43106592-3F7C0401-B548-4C5C-874A-B538E9B4BE59Q43563654-EE0BFC7C-894D-4AD2-8AC7-3211AD090413Q44996485-28A10EB0-F072-48FE-B235-66392BAA7E37Q46273981-29438445-D896-445B-8CA4-2B907849EE7CQ47168995-7A29C654-B909-422B-BFAC-89196081142DQ47787987-85A03A3B-8C56-4CFD-BBED-0660AC1AFCD7Q51072227-D74892F6-D246-41E6-AD44-0471931EE9CFQ51261899-1651F99C-B855-45B8-8BCA-B57B3B583C28
P2860
Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@ast
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@en
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@nl
type
label
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@ast
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@en
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@nl
prefLabel
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@ast
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@en
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@nl
P2093
P1433
P1476
Theranostic liposomes of TPGS ...... of docetaxel and quantum dots.
@en
P2093
Anandhkumar Raju
Madaswamy S Muthu
Si-Shen Feng
Sneha A Kulkarni
P304
P356
10.1016/J.BIOMATERIALS.2012.01.036
P577
2012-02-04T00:00:00Z